个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共5条记录   ORAL FINGOLIMOD FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS [作者：Vosiliou, S,期刊：Drugs of today, 页码：315-325 , 文章类型： Article，,卷期：2010年46-5] The sphingosine-l-phosphate receptor modulator fingolimod (FTY-720), which acts by preventing lymphocyte egress from lymph nodes thus reducing lymphocyte infiltration into the central nervous system (CNS), represents a n... GUANFACINE EXTENDED RELEASE IN THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN AND ADOLESCENTS [作者：Connor, DF; Rubin, J,期刊：Drugs of today, 页码：299-314 , 文章类型： Article，,卷期：2010年46-5] Extended-release guanfacine (Intuniv(TM)) is a novel long-acting, once-daily formulation of guanfacine indicated for attention deficit hyperactivity disorder (ADHD) in 6 to 77 year old children and adolescents. In doses ... MIFAMURTIDE IN OSTEOSARCOMA-A PRACTICAL REVIEW [作者：Anderson, PM; Tomaras, M; McConnell, K,期刊：Drugs of today, 页码：327-337 , 文章类型： Review，,卷期：2010年46-5] Mifamurtide, also known as liposomal muramyl tripeptide phosphatidyl ethanolamine (L-MTP-PE), has been approved for the treatment of osteosarcoma in Europe. Mifamurtide's rational drug design employs MTP-PE for macrophag... IMPORTANCE OF A FIXED COMBINATION OF TELMISARTAN AND AMLODIPINE FOR THE TREATMENT OF HYPERTENSION [作者：Ahrens, K; Bramlage, P,期刊：Drugs of today, 页码：339-350 , 文章类型： Review，,卷期：2010年46-5] Patients with moderate to severe hypertension frequently require 2 antihypertensives to achieve blood pressure (BP) control. The combination telmisartan/amlodipine is especially suitable for the treatment of severely hyp... VITAMIN D ANALOGUE-BASED THERAPIES FOR PSORIASIS [作者：O'Neill, JL; Feldman, SR,期刊：Drugs of today, 页码：351-360 , 文章类型： Review，,卷期：2010年46-5] Topical vitamin D3 analogues are a mainstay of treatment in mild to moderate plaque psoriasis. Vitamin D3 analogues exert their effect in psoriasis via binding nuclear vitamin D3 receptors on genes involved in cellular p...